tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CMND Stock Latest News

Clearmind Medicine announces international patent application for Ibogaine combo
The FlyClearmind Medicine announces international patent application for Ibogaine combo
4d ago
CMND
SPRC
SciSparc publishes patent application in collaboration with Clearmind Medicine
PremiumThe Fly
SciSparc publishes patent application in collaboration with Clearmind Medicine
4d ago
CMND
SPRC
Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy
PremiumPress Releases
Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy
4d ago
CMND
Clearmind, Yissum file international patent application on psychedelic compounds
PremiumThe Fly
Clearmind, Yissum file international patent application on psychedelic compounds
8d ago
CMND
Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment
PremiumPress Releases
Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment
8d ago
CMND
SciSparc announces publication of international patent application
PremiumThe FlySciSparc announces publication of international patent application
14d ago
CMND
SPRC
Clearmind announces publication of international patent application
Premium
The Fly
Clearmind announces publication of international patent application
14d ago
CMND
SPRC
Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
Premium
Press Releases
Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
14d ago
CMND
Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment
PremiumPress Releases
Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment
22d ago
CMND
SciSparc, Clearmind Medicine deal leads to publication of ketamine combo
PremiumThe Fly
SciSparc, Clearmind Medicine deal leads to publication of ketamine combo
22d ago
CMND
SPRC
Rising High: Clearmind granted patent approval for binge behavior treatment
PremiumThe Fly
Rising High: Clearmind granted patent approval for binge behavior treatment
29d ago
ACB
CGC
Closing Bell Movers: Clearmind jumps after patent approval for binge treatment
PremiumThe Fly
Closing Bell Movers: Clearmind jumps after patent approval for binge treatment
30d ago
TD
ZM
Clearmind Medicine granted new patent approval from USPTO
PremiumThe FlyClearmind Medicine granted new patent approval from USPTO
30d ago
CMND
Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment
Premium
Press Releases
Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment
30d ago
CMND
Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders
Premium
Press Releases
Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders
1M ago
CMND
Clearmind Medicine submits patent application under PCT
PremiumThe Fly
Clearmind Medicine submits patent application under PCT
1M ago
CMND
Clearmind Medicine announces publication on MEAI potential in weight loss
PremiumThe Fly
Clearmind Medicine announces publication on MEAI potential in weight loss
2M ago
CMND
SciSparc announces publication of article on MEAI potential in weight loss
PremiumThe Fly
SciSparc announces publication of article on MEAI potential in weight loss
2M ago
CMND
SPRC
Clearmind Medicine: New Scientific Publication Shows MEAI’s Potential as a Novel Weight Loss Drug
PremiumPress Releases
Clearmind Medicine: New Scientific Publication Shows MEAI’s Potential as a Novel Weight Loss Drug
2M ago
CMND
Clearmind Medicine announces participation in Psychedelic Medicine – Israel 2024
PremiumThe FlyClearmind Medicine announces participation in Psychedelic Medicine – Israel 2024
2M ago
CMND
Clearmind Medicine Concludes the Successful Participation in the Psychedelic Medicine – Israel 2024 Conference: Presented Industry Leaders its Groundbreaking Research
Premium
Press Releases
Clearmind Medicine Concludes the Successful Participation in the Psychedelic Medicine – Israel 2024 Conference: Presented Industry Leaders its Groundbreaking Research
2M ago
CMND
Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage Product
Premium
Press Releases
Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage Product
2M ago
CMND

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >